An adequately robust early TNF-α response is a hallmark of survival following trauma/hemorrhage

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Namas, Rajaie ^a   Ghuma, Ali ^a   Torres, Andres ^a   Polanco, Patricio ^a   Gomez, Hernando ^a   Barclay, Derek ^a   Gordon, Lisa ^a   Zenker, Sven ^b,c,d   Kim, Hyung Kook ^b   Hermus, Linda ^a   Zamora, Ruben ^a   Rosengart, Matthew R ^a   Clermont, Gilles ^b,c   Peitzman, Andrew ^a   Billiar, Timothy R ^a,c   Ochoa, Juan ^a,c   Pinsky, Michael R ^b,c   Puyana, Juan Carlos ^a,b,c   Vodovotz, Yoram ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; NITRATE; NITROGEN DIOXIDE; TUMOR NECROSIS FACTOR ALPHA; NITRITE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; AWARDS AND PRIZES; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GERMANY; HEMORRHAGIC SHOCK; HUMAN; HUMAN TISSUE; HYPOTHESIS; INFLAMMATION; INJURY; INJURY SEVERITY; MALE; NONHUMAN; PROTECTION; SCORING SYSTEM; SURVIVAL; SWINE; THORACOTOMY; ANIMAL; BLOOD; DISEASE MODEL; MIDDLE AGED; TIME;

SUIDAE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NITRATES; NITRITES; SHOCK, HEMORRHAGIC; SURVIVAL ANALYSIS; SUS SCROFA; THORACOTOMY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949531330     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008406     Document Type: Article

References (81)

1. Cocchi MN, Kimlin E, Walsh M, Donnino MW (2007) Identification and resuscitation of the trauma patient in shock. Emerg Med Clin North Am 25: 623-42.
2. Kung HC, Hoyert DL, Xu J, Murphy SL (2008) Deaths: final data for 2005. Natl Vital Stat Rep 56: 1-120.
3. Kauvar DS, Lefering R, Wade CE (2006) Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 60: S3-11.
4. Bickell WH, Wall MJ Jr, Pepe PE, Martin RR, Ginger VF, et al. (1994) Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 331: 1105-1109.
5. Rose S, Marzi I (1998) Mediators in polytrauma-pathophysiological significance and clinical relevance. Langenbecks Arch Surg 383: 199-208.
6. Levy RM, Mollen KP, Prince JM, Kaczorowski DJ, Vallabhaneni R, et al. (2007) Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol 293: R1538-R1544.
7. DeLong WG, Jr, Born CT (2004) Cytokines in patients with polytrauma. Clin Orthop Relat Res. 57-65.
8. Nathan C, Sporn M (1991) Cytokines in context. J Cell Biol 113: 981-986.
9. Nathan C (2002) Points of control in inflammation. Nature 420: 846-852.
10. McDaniel DO, Hamilton J, Brock M, May W, Calcote L, et al. (2007) Molecular analysis of inflammatory markers in trauma patients at risk of postinjury complications. J Trauma 63: 147-157.
11. Dinarello CA (2000) Proinflammatory cytokines. Chest 118: 503-508.
12. Waxman K (1996) Shock: ischemia, reperfusion, and inflammation. New Horiz 4: 153-160.
13. Peitzman AB, Billiar TR, Harbrecht BG, Kelly E, Udekwu AO, et al. (1995) Hemorrhagic shock. Curr Probl Surg 32: 925-1002.
14. Vodovotz Y, Csete M, Bartels J, Chang S, An G (2008) Translational systems biology of inflammation. PLoS Comput Biol 4: e1000014.
15. Chow CC, Clermont G, Kumar R, Lagoa C, Tawadrous Z, et al. (2005) The acute inflammatory response in diverse shock states. Shock 24: 74-84.
16. Cobb JP, Mindrinos MN, Miller-Graziano C, Calvano SE, Baker HV, et al. (2005) Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A 102: 4801-4806.
17. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94: 3195-3199.
18. Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, et al. (2006) Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock 26: 430-437.
19. Youn YK, Lalonde C, Demling R (1992) The role of mediators in the response to thermal injury. World J Surg 16: 30-36.
20. Smith RM, Giannoudis PV (1998) Trauma and the immune response. J R Soc Med 91: 417-420.
21. Chaudry IH, Ayala A, Ertel W, Stephan RN (1990) Hemorrhage and resuscitation: immunological aspects. Am J Physiol 259: R663-R678.
22. Marcu AC, Paccione KE, Barbee RW, Diegelmann RF, Ivatury RR, et al. (2007) Androstenetriol immunomodulation improves survival in a severe trauma hemorrhage shock model. J Trauma 63: 662-669.
23. Letterio JJ, Vodovotz Y, Bogdan C (2000) TGF-b and IL-10: Inhibitory Cytokines Regulating Immunity and the Response to Infection. Novel Cytokine Inhibitors. 217-242.
24. Karakozis S, Hinds M, Cook JW, Kim D, Provido H, et al. (2000) The effects of interleukin-10 in hemorrhagic shock. J Surg Res 90: 109-112.
25. Pape HC, Tsukamoto T, Kobbe P, Tarkin I, Katsoulis S, et al. (2007) Assessment of the clinical course with inflammatory parameters. Injury 38: 1358-1364.
26. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, et al. (1995) Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23: 1638-1652.
27. Jarrar D, Chaudry IH, Wang P (1999) Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches (Review). Int J Mol Med 4: 575-583.
28. Dimopoulou I, Orfanos S, Kotanidou A, Livaditi O, Giamarellos-Bourboulis E, et al. (2008) Plasma pro-and anti-inflammatory cytokine levels and outcome prediction in unselected critically ill patients. Cytokine 41: 263-267.
29. Batistaki C, Kostopanagiotou G, Myrianthefs P, Dimas C, Matsota P, et al. (2008) Effect of exogenous catecholamines on tumor necrosis factor alpha, interleukin-6, interleukin-10 and beta-endorphin levels following severe trauma. Vascul Pharmacol 48: 85-91.
30. Roumen RM, Hendriks T, van d V, Nieuwenhuijzen GA, Sauerwein RW, et al. (1993) Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 218: 769-776.
31. Foex BA (1999) Systemic responses to trauma. Br Med Bull 55: 726-743.
32. Endo S, Inada K, Yamada Y, Takakuwa T, Kasai T, et al. (1994) Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock. Crit Care Med 22: 949-955.
33. Molina PE (2001) Noradrenergic inhibition of TNF upregulation in hemorrhagic shock. Neuroimmunomodulation 9: 125-133.
34. Demaria EJ, Pellicane JV, Lee RB (1993) Hemorrhagic shock in endotoxin-resistant mice: improved survival unrelated to deficient production of tumor necrosis factor. J Trauma 35: 720-724.
35. Ayala A, Wang P, Ba ZF, Perrin MM, Ertel W, et al. (1991) Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol 260: R167-R171.
36. Bemelmans MH, Gouma DJ, Greve JW, Buurman WA (1993) Effect of antitumour necrosis factor treatment on circulating tumour necrosis factor levels and mortality after surgery in jaundiced mice. Br J Surg 80: 1055-1058.
37. DeMaria EJ, Pellicane JV, Lee RB (1993) Hemorrhagic shock in endotoxin-resistant mice: improved survival unrelated to deficient production of tumor necrosis factor. J Trauma 35: 720-724.
38. Zingarelli B, Squadrito F, Altavilla D, Calapai G, Di RM, et al. (1994) Role of tumor necrosis factor-alpha in acute hypovolemic hemorrhagic shock in rats. Am J Physiol 266: H1512-H1515.
39. Marzi I, Bauer M, Secchi A, Bahrami S, Redi H, et al. (1995) Effect of anti-tumor necrosis factor alpha on leukocyte adhesion in the liver after hemorrhagic shock: an intravital microscopic study in the rat. Shock 3: 27-33.
40. Abraham E, Jesmok G, Tuder R, Allbee J, Chang YH (1995) Contribution of tumor necrosis factor-alpha to pulmonary cytokine expression and lung injury after hemorrhage and resuscitation. Crit Care Med 23: 1319-1326.
41. Foex BA, Lamb WR, Roberts TE, Brear SG, Macartney I, et al. (1993) Early cytokine response to multiple injury. Injury 24: 373-376.
42. Bianchi ME, Manfredi AA (2007) High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 220: 35-46.
43. Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81: 1-5.
44. Wang W, Smail N, Wang P, Chaudry IH (1998) Increased gut permeability after hemorrhage is associated with upregulation of local and systemic IL-6. J Surg Res 79: 39-46.
45. Toth B, Yokoyama Y, Schwacha MG, George RL, Rue LW III, et al. (2004) Insights into the role of interleukin-6 in the induction of hepatic injury after trauma-hemorrhagic shock. J Appl Physiol 97: 2184-2189.
46. Pasquale MD, Cipolle MD, Monaco J, Simon N (1996) Early inflammatory response correlates with the severity of injury. Crit Care Med 24: 1238-1242.
47. Mimasaka S, Hashiyada M, Nata M, Funayama M (2001) Correlation between serum IL-6 levels and death: usefulness in diagnosis of ''traumatic shock''? Tohoku J Exp Med 193: 319-324.
48. Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA (2002) Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 17: 463-467.
49. Sperry JL, Friese RS, Frankel HL, West MA, Cuschieri J, et al. (2008) Male gender is associated with excessive IL-6 expression following severe injury. J Trauma 64: 572-578.
50. Maier B, Lefering R, Lehnert M, Laurer HL, Steudel WI, et al. (2007) Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock 28: 668-674.
51. Cavaillon JM (1994) Cytokines and macrophages. Biomed Pharmacother 48: 445-453.
52. Marie C, Pitton C, Fitting C, Cavaillon JM (1996) Regulation by anti-inflammatory cytokines (IL-4, IL-10, IL-13, TGFbeta)of interleukin-8 production by LPS-and/or TNFalpha-activated human polymorphonuclear cells. Mediators Inflamm 5: 334-340.
53. Sherry RM, Cue JI, Goddard JK, Parramore JB, DiPiro JT (1996) Interleukin- 10 is associated with the development of sepsis in trauma patients. J Trauma 40: 613-616.
54. Schwacha MG, Schneider CP, Bland KI, Chaudry IH (2001) Resistance of macrophages to the suppressive effect of interleukin-10 following thermal injury. Am J Physiol Cell Physiol 281: C1180-C1187.
55. Schneider CP, Schwacha MG, Chaudry IH (2004) The role of interleukin-10 in the regulation of the systemic inflammatory response following trauma-hemorrhage. Biochim Biophys Acta 1689: 22-32.
56. Bogdan C, Vodovotz Y, Nathan C (1991) Macrophage deactivation by interleukin 10. J Exp Med 174: 1549-1555.
57. Bogdan C, Paik J, Vodovotz Y, Nathan C (1992) Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 267: 23301-23308.
58. Ayala A, Lehman DL, Herdon CD, Chaudry IH (1994) Mechanism of enhanced susceptibility to sepsis following hemorrhage. Interleukin-10 suppression of T-cell response is mediated by eicosanoid-induced interleukin-4 release. Arch Surg 129(11): 1172-1178.
59. Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, et al. (1998) Sympathetic activation triggers systemic interleukin-10 release in immunode pression induced by brain injury. Nat Med 4: 808-813.
60. Platzer C, Docke W, Volk H, Prosch S (2000) Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/ enhancer activity in monocytic cells. J Neuroimmunol 105: 31-38.
61. van der Poll T, Marchant A, Buurman WA, Berman L, Keogh CV, et al. (1995) Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 155: 5397-5401.
62. Rogy MA, Auffenberg T, Espat NJ, Philip R, Remick D, et al. (1995) Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J Exp Med 181: 2289-2293.
63. Huber TS, Gaines GC, Welborn MB III, Rosenberg JJ, Seeger JM, et al. (2000) Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome: IL-10 and ischemia/reperfusion injury as a new paradigm. Shock 13: 425-434.
64. Engles RE, Huber TS, Zander DS, Hess PJ, Welborn MB, et al. (1997) Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia-reperfusion injury. J Surg Res 69: 425-428.
65. Wang P, Ba ZF, Chaudry IH (1993) Endothelial cell dysfunction occurs after hemorrhage in nonheparinized but not in preheparinized models. J Surg Res 54: 499-506.
66. Angele MK, Smail N, Wang P, Cioffi WG, Bland KI, et al. (1998) L-arginine restores the depressed cardiac output and regional perfusion after trauma-hemorrhage. Surgery 124: 394-401.
67. Fruchterman TM, Spain DA, Wilson MA, Harris PD, Garrison RN (1998) Selective microvascular endothelial cell dysfunction in the small intestine following resuscitated hemorrhagic shock. Shock 10: 417-422.
68. Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064.
69. Gebhard F, Nussler AK, Rosch M, Pfetsch H, Kinzl L, et al. (1998) Early posttraumatic increase in production of nitric oxide in humans. Shock 10: 237-242.
70. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, et al. (1991) Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214: 621-626.
71. Gebhard F, Pfetsch H, Steinbach G, Strecker W, Kinzl L, et al. (2000) Is interleukin 6 an early marker of injury severity following major trauma in humans? Arch Surg 135: 291-295.
72. Thiemermann C, Szabo C, Mitchell JA, Vane JR (1993) Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci U S A 90: 267-271.
73. Collins J, Vodovotz Y, Billiar TR (2001) Biology of Nitric Oxide: Measurement, Modulation, and Models. In: Souba W, Wilmore D, eds. Surgical Research. San Diego: Academic Press. pp 949-969.
74. Rizoli SB, Rhind SG, Shek PN, Inaba K, Filips D, et al. (2006) The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: a randomized, controlled, double-blinded trial. Ann Surg 243: 47-57.
75. Damas P, Ledoux D, Nys M, Vrindts Y, de GD, et al. (1992) Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 215: 356-362.
76. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, et al. (1989) Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17: 975-978.
77. Wu HP, Chen CK, Chung K, Tseng JC, Hua CC, et al. (2009) Serial cytokine levels in patients with severe sepsis. Inflamm Res.
78. Rivers EP, Nguyen HB, Huang DT, Donnino M (2004) Early goal-directed therapy. Crit Care Med 32: 314-315.
79. Pincus SM, Goldberger AL (1994) Physiological time-series analysis: what does regularity quantify? Am J Physiol 266: H1643-H1656.
80. Godin PJ, Fleisher LA, Eidsath A, Vandivier RW, Preas HL, et al. (1996) Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trial. Crit Care Med 24: 1117-1124.
81. Buchman TG (2004) Nonlinear dynamics, complex systems, and the pathobiology of critical illness. Curr Opin Crit Care 10: 378-382.